Machine Learning for Determining Lateral Flow Device Results in Asymptomatic Population: A Diagnostic Accuracy Study
Preprint - The Lancet
Consortium, AI LFD and Banathy, Robert and Branigan, Mark and Lewis-Borman, Paul and Patel, Nishali and Lee, Lennard and Caiado, Camila C. S. and Dijkstra, Anna and Chudzik, Piotr and Yousefi, Paria and Javer, Avelino and Van Meurs, Bram and Tarassenko, Lionel and Irving, Benjamin and Whalley, Celina and Lal, Neeraj and Robbins, Helen and Leung, Elaine and Beggs, Andrew D.
Early risk assessment for COVID-19 patients from emergency department data using machine learning
Frank S. Heldt, Marcela P. Vizcaychipi, Sophie Peacock, Mattia Cinelli, Lachlan McLachlan, Fernando Andreotti, Stojan Jovanović, Robert Dürichen, Nadezda Lipunova, Robert A. Fletcher, Anne Hancock, Alex McCarthy, Richard A. Pointon, Alexander Brown, James Eaton, Roberto Liddi, Lucy Mackillop, Lionel Tarassenko, Rabia T. Khan
Risk factors for clinical progression in patients with COVID-19: a retrospective study of electronic health record data in the United Kingdom
Preprint - medRxiv
Robert A Fletcher, Thomas Matcham,Marta Tibúrcio, Arseni Anisimovich, Stojan Jovanović, Luca Albergante, Nadezda Lipunova, Anne Hancock, Lucy Mackillop, Lionel Tarassenko, Alex McCarthy, Marcela P Vizcaychipi, Rabia Tahir Khan
Sensyne Health Group Limited. registered in England and Wales No. 11240986 is a trading company of Sensyne Health plc registered in England and Wales No. 11425451
Registered office: Schrödinger Building, Heatley Road, Oxford Science Park, Oxford, OX4 4GE, United Kingdom.
Note: Not all Sensyne Health products are available in all territories, for further information contact head office.
In support of the ‘Understanding Patient Data’ initiative, Sensyne Health cite that its “work uses data provided by patients and collected by the NHS as part of their care and support”. #datasaveslives